EmployeesSellingAndAdminstrativeMember Related Party [Axis] EmployeesResearchAndDevelopmentMember DirectorSellingAndAdminstrativeMember ConsultantsSellingAndAdminstrativeMember ConsultantsResearchAndDevelopment [Member] TenPercentConvertibleNotesPayableMember DebtInstrument [Axis] SevenPointFiveConvertibleNotesPayableMember ConsultantsMember Warrant [Member] Class of Warrant or Right [Axis] FederalMember ComponentOfOtherOperatingCostAndExpenseGeneral [Axis] CaliforniaMember Employee and Directors Restricted Stock Units [Member] Award Type [Axis] Stock Option Plan [Member] Pipe Investors DermaStar April PPM Underwriter Warrants IR Consultant Restricted Stock Units (RSUs) [Member] Stock Option Plan [Member] Stock Option [Member] Major Types of Debt and Equity Securities [Axis] Stock Option [Member] Stock Option [Member] Stock Option [Member] Stock Option [Member] Stock Option [Member] Stock Option [Member] Warrant Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current assets Cash and cash equivalents Restricted short-term investment Prepaid expenses and other current assets Deferred offering costs Total current assets Furniture and equipment, net TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities Accounts payable and accrued expenses Accrued Phase 3 expenses Accrued payroll and related liabilities Deferred revenue Total current liabilities Commitments and contingencies STOCKHOLDERS' EQUITY Common stock, $0.001 par value, 395,000,000 shares authorized, 8,888,250 and 6,772,066 shares issued and outstanding at March 31, 2013 and December 31, 2012, respectively Additional paid-in capital Deficit accumulated during the development stage TOTAL STOCKHOLDERS' EQUITY TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Common stock, par value Common stock, authorized shares Common stock, issued shares Common stock, outstanding shares Income Statement [Abstract] Revenues: License revenues Operating Expenses: Selling, general and administrative Research and development Loss from operations Other income (expense): Interest expense Interest income Loss from extinguishment of debt Gain on settlement Gain on forgiveness of liabilities Total other income (expense), net Net loss Deemed dividend to preferred stockholders Net loss attributable to common stockholders Net loss per share of common stock, basic and diluted: Weighted average number of shares of common stockoutstanding, basic and diluted Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Net loss Adjustments to reconcile net loss to net cash used in operating activities: Estimated fair value of contributed services Gain on forgiveness of liabilities Amortization of prepaid consulting fees Depreciation Loss on extinguishment of debt Non-cash interest on notes payable Stock-based compensation Payments made on behalf of Company by related party Changes in assets and liabilities: Prepaid consulting costs Prepaid expenses and other current assets Accounts payable and accrued expenses Accrued Phase 3 expenses Accrued payroll Deferred revenue NET CASH USED IN OPERATING ACTIVITIES CASH FLOWS FROM INVESTING ACTIVITIES Purchase of restricted short-term investment Purchases of fixed assets NET CASH USED IN INVESTING ACTIVITIES CASH FLOWS FROM FINANCING ACTIVITIES Payment for settlement of shares in connection with reverse stock split Proceeds from issuance of notes payable to a related party Proceeds received in connection with debt modification Proceeds from issuance of preferred stock Proceeds from notes payable Preferred stock deemed dividend paid at conversion Cash advances from related party Repayment of advances from related party Capital contributions Net proceeds from purchase of common stock and exercise of warrants and stock options Proceeds from issuance of common stock and warrants for cash, net of offering costs NET CASH PROVIDED BY FINANCING ACTIVITIES NET CHANGE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, beginning of period CASH AND CASH EQUIVALENTS, end of period SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Cash paid for income taxes SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES: Issuance of and adjustment to common stock and warrants to consulting firms for prepaid consulting fees Conversion of related party accounts payable into common stock Conversion of notes payable and accrued interest into common stock Forgiveness of notes payable and accrued interest to shareholders Conversion of advances to notes payable to shareholders Accretion of preferred stock discount Related party acquisition of Phase 3 liabilities Conversion of preferred stock into common stock Reclassification of deferred offering costs in connection with equity offering Accounting Policies [Abstract] NOTE 1. OVERVIEW AND BASIS OF PRESENTATION Notes to Financial Statements NOTE 2. SHORT-TERM RESTICTED INVESTMENT Debt Disclosure [Abstract] NOTE 3. ACCOUNTS PAYABLE AND ACCRUED EXPENSES Equity [Abstract] NOTE 4. STOCKHOLDERS' EQUITY AND STOCK- BASED COMPENSATION Commitments and Contingencies Disclosure [Abstract] NOTE 5. COMMITMENTS AND CONTINGENCIES Subsequent Events [Abstract] NOTE 6. SUBSEQUENT EVENTS Company and Background Basis of Presentation Principles of Consolidation Development Stage Enterprise Research and Development Revenue Recognition and Deferred Revenue Income Taxes Cash and Cash Equivalents Concentrations of Credit Risk Deferred Offering Costs Furniture and Equipment Deferred Rent Fair Value Measurements Stock-Based Compensation Basic and Diluted Loss per Common Share Use of Estimates Reclassifications Recently Adopted Accounting Pronouncements Stock-Based Compensation Earnings per share Schedule of accounts payable and accrued expenses Statement [Table] Statement [Line Items] Schedule of Plan Activity Schedule of fair value assumption Schedule of shares outstanding and exercisable Compensation Expenses Overview And Basis Of Presentation Details 1 Numerator - loss attributable to common stockholders Denominator - weighted average number of shares outstanding, basic and diluted Loss per share, basic and diluted Overview And Basis Of Presentation Details Narrative Accumulated deficit Revenue Cash deposits Unvested restricted stock units ("RSUs") and warrants Short-Term Resticted Investment Details Narrative Certificate of deposit Accounts Payable And Accrued Expenses Details Accounts payable Accrued offering costs Deferred rent Other accrued expenses Stock-based compensation accrual Total accounts payable and accrued expenses Accounts Payable And Accrued Expenses Details Narrative Common stock Common stock from unissued stock options Number of Shares Beginning Balance Granted Vested Cancelled/Forfeited Ending, Unvested Weighted Average Grant Date Fair Value Beginning, Unvested Granted Vested Cancelled Ending, Unvested Aggregate Intrinsic Value Beginning Balance Granted Vested Cancelled Ending Balance Stockholders Equity And Stock - Based Compensation Details 1 Number of shares Beginning Balance Exercised Ending Balance Exercisable Ending Balance Vested and expected to vest - September 30, 2012 Weighted Avg. Exercise Price Beginning Balance Granted Exercised Cancelled/Forfeited Ending Balance Exercisable Ending Balance Vested and expected to vest - September 30, 2012 Weighted Avg. Remaining Contractual Life Ending Balance Exercisable Ending Balance Vested and expected to vest - September 30, 2012 Exercisable Ending Balance Vested and expected to vest - September 30, 2012 Stockholders Equity And Stock - Based Compensation Details 2 Weighted-average fair value of options granted Expected terms Expected volatility minimum Expected volatility maximum Risk-free interest rate Minimum Risk-free interest rate Maximum Expected Dividend Yield Range of Exercise Prices Minimum Range of Exercise Prices Maximum Number Outstanding Weighted Average Remaining Contractual Life in Years Weighted Average Outstanding Exercise Price Number Exercisable Weighted Average Exercisable Exercise Price Expired Weighted average remaining contractual life of the outstanding warrants in years - March 31, 2013 Expired Expected terms Minimum Expected terms Maximum Dividend yield Issue Date Warrants Outstanding Exercise Price Warrants Exercisable Expiration Date Preferred authorized, shares held Preferred stock, par value Preferred stock, shares issued Preferred stock, shares outstanding Stock based compensation Unrecognized compensation expense related to Restricted Stock Units Weighted-average period of Restricted Stock Units Stock-based compensation of Restricted Stock Units Unrecognized compensation expense related to unvested stock options Weighted-average remaining vesting period Remeasured fair value of the unvested portion of the stock option stock-based compensation for stock options Commitments And Contingencies Details Narrative Operating lease Expiry Operating lease due current Operating lease due next year Operating lease due thereafter Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Federal Member. California. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. StockOptionPlanMember StockOption1Member StockOption2Member StockOption3Member StockOption4Member StockOption5Member StockOption6Member Assets, Current Assets Liabilities, Current Development Stage Enterprise, Deficit Accumulated During Development Stage Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Income (Loss) Interest Expense Other Nonoperating Expense Preferred Stock Dividends and Other Adjustments Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Increase (Decrease) in Deferred Revenue Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities PaymentForSettlementOfSharesInConnectionWithReverseStockSplit Repayments of Related Party Debt Net Cash Provided by (Used in) Financing Activities Schedule of Share-based Compensation, Activity [Table Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue1 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue1 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value